Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
EAF2 knockdown enhanced endogenous FOXA1 protein level.
»
11/20/14
PLCε knockdown inhibits prostate cancer cell proliferation via suppression of notch signalling and nuclear translocation of the androgen receptor.
Activation of both the Notch and AR signalling pathways is involved in PLCε-mediated oncogenic effects in PCa.
»
12/08/14
Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.
Significant increase treatment effectiveness with erlotinib in patients with normal levels of sodium to hyponatremic patients.
»
12/16/14
MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation.
Tumors with over-expression of MAD2 were associated with the progression of histological grade.
»
12/16/14
p53 up-regulation during colorectal carcinogenesis.
Extensive p53 up-regulation predominated in the submucosal carcinomatous tissue (87%) and in overt carcinomas (89%).
»
12/16/14
MiR-20a Promotes Cervical Cancer Proliferation and Metastasis In Vitro and In Vivo.
miR-20a suppresses the proliferation, migration and invasion of cervical cancer cell through targeting ATG7 and TIMP2.
»
03/27/15
Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
Variant types of DNA repair genes play an important role in modifying individual susceptibility to SCC.
»
03/27/15
P1.01A phase 3 study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with advanced breast cancer (EMBRACA).
Talazoparib has shown promising single-agent antitumor efficacy in several solid tumor types and generally well tolerated in an ongoing Phase 1/2 clinical study.
»
03/22/15
Inhibition of breast cancer invasion by TIS21(/BTG2/Pc3)-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
TIS21(/BTG2/Pc3)-Akt1 inhibited Sp1-Nox4-ROS cascade.
»
08/02/14
Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York.
Long-chain ω-3 PUFA intake from fish and other dietary sources may provide a potential strategy to improve survival after breast cancer.
»
09/07/14
< Prev
Next >